Home
Name
Mito-FLAG
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for Mito-FLAG
Name
Alternate Names
CL 232315
Mitoxantrone Hydrochloride
Mitozantrone
Novantrone
Abbreviations
DAD
DHAD
DHAQ
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
301739
Primary Site
Histology
None
Remarks
Antibiotic-class antineoplastic. FDA approved uses in adult acute non-lymphocytic leukemia, and prostate cancer pain reduction in combination with prednisone. Novantrone is a synthetic antineoplastic anthracenedione
Coding
This drug should be coded
Name
Alternate Names
2-FLAMP
2-Fluoro-ARA AMP
2-Fluoro-ara-AMP
Fludara
Fludarabine Monophosphate
Fludarabine Phosphate
Abbreviations
2-FAMP
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
312887
Primary Site
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
megakaryocyte colony stimulating factor
Abbreviations
None
Category
Ancillary Agent
Subcategory
None
NSC Number
None
Primary Site
None
Histology
None
Remarks
None
Coding
This drug should NOT be coded
Name
Alternate Names
AC-1075
Alexan
Ara-cytidine
Arabinocytidine
Arabinosylcytosine
Beta-Arabinosylcytosine
Cytarabin
Cytarabine
Cytarabinoside
Cytosar
Cytosar-U
Cytosine Arabinoside
Cytosine arabinoside hydrochloride
Spongocytidine HCL
Tarabine
Tarabine PFS
U-19920
U-19920A
WR-28453
Abbreviations
ara-C
CA
HDA
HDARA-C
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
063878
63878
Primary Site
Histology
None
Remarks
Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)
Coding
This drug should be coded
